Randomized,double-blind,placebo-controlled,international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease |
| |
Authors: | Topol Eric J,Easton Donald,Harrington Robert A,Amarenco Pierre,Califf Robert M,Graffagnino Carmen,Davis Stephen,Diener Hans-Christophe,Ferguson James,Fitzgerald Desmond,Granett Jeffrey,Shuaib Ashfaq,Koudstaal Peter J,Theroux Pierre,Van de Werf Frans,Sigmon Kristina,Pieper Karen,Vallee Marc,Willerson James T Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators |
| |
Affiliation: | Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. topole@ccf.org |
| |
Abstract: | |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|